RECTAL ADMINISTRATION OF ROFLUMILAST FOR THE TREATMENT OF CROHN'S DISEASE
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Apr 4, 2024
app pub date -
Sep 8, 2023
filing date -
Sep 29, 2022
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A method for treating Crohn's Disease in a subject in need thereof is provided. The method includes administering rectally to the subject a therapeutically effective amount of a composition comprising roflumilast. The composition may be administered repetitively over a period of days and may contain or be co-administered with one or more agents different from roflumilast that are directed against bowel disease. A suppository dosage form comprising roflumilast and a pharmaceutically acceptable carrier are also provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully